Protective immunity to toxoplasmosis in pigs vaccinated with a nonpersistent strain of Toxoplasma gondii.
The RH strain of Toxoplasma gondii is highly virulent; 1 infective organism is uniformly lethal for mice. Three pigs inoculated SC with 10(3) tachyzoites of the RH strain developed fever, but otherwise remained normal, and T gondii was not demonstrated in their tissues by bioassay into mice. To determine whether vaccination with the RH strain could induce protective immunity to oral challenge with T gondii oocysts, 12 pigs were divided into 3 groups (A, B, C) of 4 pigs each. Pigs in groups A and B were inoculated IM with 10(6) tachyzoites of the RH strain and 4 pigs in group C served as uninoculated controls. Except for fever, the pigs remained clinically normal after inoculation with the RH strain and T gondii was not found by bioassay in mice of tissues from 4 pigs euthanatized 64 days after inoculation. Pigs in groups B and C were challenge-inoculated orally with 10(4) (4 pigs) or 10(5) (4 pigs) T gondii oocysts 72 days after vaccination with the RH strain. The previously uninoculated pigs developed fever, anorexia, and diarrhea from 3 to 8 days after the oocyst challenge. One of the 2 pigs given 10(5) oocysts became moribund because of toxoplasmosis and was euthanatized 9 days after inoculation. Pigs vaccinated with the RH strain remained free of clinical signs after challenge with oocysts. Results of the bioassays indicated that fewer tissue cysts developed in the RH strain-vaccinated pigs than in the previously uninoculated control pigs.
Zoonotic Diseases Laboratory, Livestock and Poultry Sciences Institute, USDA, Agricultural Research Service, Beltsville, MD 20705-2350.
J P
JP
Dubey
J F
JF
Urban
S W
SW
Davis
D000818:Animals; D000855:Anorexia / Q000662:veterinary; D000913:Antibodies, Protozoan / Q000096:biosynthesis; D001681:Biological Assay; D003967:Diarrhea / Q000662:veterinary; D005334:Fever / Q000662:veterinary; D051379:Mice; D013552:Swine; D013553:Swine Diseases / Q000473:pathology / Q000517:prevention & control*; D014122:Toxoplasma / Q000276:immunology* / Q000302:isolation & purification; D014124:Toxoplasmosis, Animal / Q000473:pathology / Q000517:prevention & control*; D014611:Vaccination / Q000662:veterinary*
D000913:Antibodies, Protozoan